Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 3 of 100
Politics
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
By
Elaine Kurtenbach
and
The Associated Press
April 15, 2025
Health
Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs
By
Ryan Hogg
April 9, 2025
Finance
Could Trump tariffs solve Ireland’s housing crisis?
By
Ryan Hogg
April 8, 2025
Newsletters
How Trump’s import tariffs shocked tech stocks
By
Andrew Nusca
April 4, 2025
Retail
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
By
AFP
April 3, 2025
Features
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By
Erika Fry
April 3, 2025
Leadership
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
By
Ryan Hogg
April 2, 2025
Health
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By
Ani Freedman
April 1, 2025
Tech
As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By
Andrew Nusca
March 31, 2025
Finance
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By
AFP
March 27, 2025
Tech
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By
Ryan Hogg
March 27, 2025
Tech
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By
Ryan Hogg
March 25, 2025
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By
Ashleigh Furlong
and
Bloomberg
March 17, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By
Wendy Barnes
March 4, 2025
Most Popular
AI
Netflix will pay you up to $700K per year—and let you work fully remote—if you can harness AI to make employees more...
By
Dave Smith
Success
‘I don’t know why I need to go to college’: Ford CEO says his Gen Z son worked as a mechanic and wondered if the 4-year...
By
Nick Lichtenberg
Success
Meet Mira Murati, the 36-year-old tech prodigy who shot to fame at OpenAI and now runs a startup that's a poaching...
By
Dave Smith